Identification |
Name: | Oxacyclotetradecane-2,10-dione,4-[(4-O-acetyl-2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-xylo-hexopyranosyl)oxy]-12-(acetyloxy)-6-[(4,6-dideoxy-3-O-methyl-b-D-xylo-hexopyranosyl)oxy]-9-hydroxy-14-[(1S,2S)-2-hydroxy-1-methylpropyl]-3,5,7,9,11,13-hexamethyl-,(3R,4S,5R,6S,7S,9S,11R,12S,13S,14R)- |
Synonyms: | Lankamycin(8CI); Oxacyclotetradecane-2,10-dione,4-[(4-O-acetyl-2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-xylo-hexopyranosyl)oxy]-12-(acetyloxy)-6-[(4,6-dideoxy-3-O-methyl-b-D-xylo-hexopyranosyl)oxy]-9-hydroxy-14-(2-hydroxy-1-methylpropyl)-3,5,7,9,11,13-hexamethyl-,[3R-[3R*,4S*,5R*,6S*,7S*,9S*,11R*,12S*,13S*,14R*(1S*,2S*)]]-;Oxacyclotetradecane, lankamycin deriv.; Kujimycin B; [3R-[3R*,4S*,5R*,6S*,7S*,9S*,11R*,12S*,13S*,14R*(1S*,2S*)]]-4-[(4-O-Acetyl-2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-xylo-hexopyranosyl)oxy]-12-(acetyloxy)-6-[(4,6-dideoxy-3-O-methyl-b-D-xylo-hexopyranosyl)oxy]-9-hydroxy-14-(2-hydroxy-1-methylpropyl)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione |
CAS: | 30042-37-6 |
Molecular Formula: | C42H72 O16 |
Molecular Weight: | 0 |
InChI: | InChI=1/C42H72O16/c1-19-17-41(12,49)37(47)24(6)35(54-28(10)44)23(5)34(21(3)26(8)43)57-39(48)25(7)36(22(4)33(19)58-40-32(46)30(50-14)16-20(2)52-40)56-31-18-42(13,51-15)38(27(9)53-31)55-29(11)45/h19-27,30-36,38,40,43,46,49H,16-18H2,1-15H3/t19-,20?,21?,22+,23-,24+,25+,26?,27?,30?,31?,32?,33+,34+,35-,36-,38?,40?,41-,42?/m0/s1 |
Molecular Structure: |
|
Properties |
Flash Point: | 238.7°C |
Boiling Point: | 846°Cat760mmHg |
Density: | 1.19g/cm3 |
Refractive index: | 1.514 |
Flash Point: | 238.7°C |
Safety Data |
|
|